ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
New patent issued to 2032 for Neuren's trofinetide in Canada
Published: 29/04/21, 09:05am (AEST)•2 pages